Excerpted from the website: Accera is a private biotechnology company engaged in the discovery and development of innovative therapeutic treatments for neurodegenerative diseases. We have developed a proprietary scientific approach to product development based upon principles of cellular neuroprotection and neuron metabolism in the brain. Our product candidates address the high unmet medical need associated with most neurodegenerative diseases where few, if any, effective therapies exist today. read more
This article uses content from
http://www.AboutUs.org
